| aa | amino-acid |
| ACE | angiotensin converting enzyme |
| Ang II | angiotensin II |
| AF | atrial fibrillation |
| ANP | atrial natriuretic peptide |
| ARB | angiotensin receptor blockers |
| ATP | adenylate triphosphates |
| BNP | B-type natriuretic peptide |
| CNP | C-type natriuretic peptide |
| CD-NP | Cenderitide |
| ECE | endothelin-converting enzyme |
| ET-1 | endothelin- 1 |
| ESC | European Society of Cardiology |
| GFR | glomerular filtration rate |
| GMP | guanylate mono phosphatase |
| HF | heart failure |
| HFrEF | heart failure with reduced ejection fraction |
| HFpEF | heart failure with preserved ejection fraction |
| HFmrEF | heart failure with mid-range ejection fraction |
| LA | left atrial |
| LAVI | left atrial indexed volume |
| LV | left ventricular |
| LVEF | left ventricular ejection fraction |
| mRNA | messenger ribonucleic acid |
| MR-proANP | middle range pro atrial natriuretic peptide |
| NEP | neutral endopeptidase |
| NHE | natrium-proton exchanger |
| NPs | natriuretic peptides |
| NPR-A | natriuretic peptide receptor A |
| NPR-B | natriuretic peptide receptor B |
| NPR-C | natriuretic peptide receptor C |
| MRAs | mineralocorticoid receptor antagonists |
| pGC | particulate guanylyl cyclase |
| RAAS | renin-angiotensin-aldosterone system |
| sGC | soluble guanylyl cyclase |
| sST2 | soluble source of tumorigenicity 2 |
| TGF ß | transforming growth factor beta |